Skip to content
Not evaluated by SAHPRA · Research & educational information only · Nothing on this site is for sale · Not medical advice · Consult a healthcare professional
Not evaluated by SAHPRA. Research & educational information only — nothing is for sale; not intended to diagnose, treat, cure or prevent any disease.
← Back to catalogue
Weight LossResearch vialGLP-1Weight lossOnce weeklySelf-mixAppetite

SEMA Self Mix (Semaglutide)

Long-acting GLP-1 agonist — slows gastric emptying and quietens appetite signalling.

Format
Research vial
Strength / pack
10mg vial
Category
Weight Loss
Appetite controlActs on hypothalamic GLP-1 receptors to reduce hunger and food preoccupation.
Steady fat lossSTEP 1 trial showed -14.9% body weight at 68 weeks versus -2.4% on placebo.
Slower gastric emptyingFood leaves the stomach more slowly, extending satiety after meals.
Glucose-dependent insulinStimulates insulin release only when blood glucose is elevated.
Semaglutide is a synthetic GLP-1 receptor agonist — a long-acting analog of the gut hormone glucagon-like peptide 1. It binds the GLP-1 receptor, which slows gastric emptying, stimulates glucose-dependent insulin release, and reduces appetite signalling in the hypothalamus. "Self mix" refers to the format: lyophilised powder reconstituted with bacteriostatic water before subcutaneous injection.
Publisher
Elegant Slimming · Mokopane, Limpopo, South Africa
Research library · nothing on this site is for sale.
Regulatory
This compound has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA).
For information purposes only — not intended to diagnose, treat, cure or prevent any disease.